Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drugs Acting on Autonomic Ganglia: Stimulants

Drugs Acting on Autonomic Ganglia: Stimulants

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...

CNS Depressants: Alcohol and Nicotine

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...

Cholinergic Receptors: Nicotinic

Cholinergic Receptors: Nicotinic

Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...

Neurochemical Transmission: Sites of Drug Action

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...

Drugs Affecting Neurotransmitter Release or Uptake

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The distribution of dissolved cadmium and its isotopes across the subarctic Pacific Ocean.

Scientific reports·2026

Same author

Particulate Cadmium Accumulation in the Mesopelagic Ocean.

Global biogeochemical cycles·2025

Same author

Dynamic proteome allocation regulates the profile of interaction of auxotrophic bacterial consortia.

Royal Society open science·2022

Same author

Continuous deacetylation of cephalosporins.

Biotechnology and bioengineering·2018

Same author

Microwave Realization of the Gaussian Symplectic Ensemble.

Physical review letters·2016

Same author

The pharmacological control of neuronal excitability in the retinal spreading depression model of migraine.

Current medicinal chemistry·2012

Search research articles

Related Experiment Video

Updated: May 25, 2026

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices

Published on: October 29, 2012

Neuroprotective properties of nicotine.

¹University of Hohenheim, Institute of Physiology, Stuttgart, Germany. michaela.sieber@uni-hohenheim.de

Current Medicinal Chemistry

|February 11, 2012

Summary

Nicotine protects retinal cells from excitotoxic damage by activating glutamate receptors. This neuroprotection involves decreased retinal spreading depression (rSD) wave velocity, suggesting a novel therapeutic pathway.

Area of Science:

Neuroscience
Ophthalmology
Pharmacology

Background:

Excitotoxic cell death is a significant cause of neuronal damage.
Retinal spreading depression (rSD) waves reflect tissue activity and vulnerability.
Nicotine's effects on neuronal function are mediated through nicotinic acetylcholine receptors (nAChRs).

Purpose of the Study:

To investigate the neuroprotective effects of nicotine against NMDA-induced excitotoxicity in retinal tissue.
To examine the impact of nicotine on rSD wave propagation velocity.
To elucidate the role of glutamate receptors in nicotine's protective mechanism.

Main Methods:

Utilized in vivo near tissue preparation of retinal tissue.
Measured intrinsic optical signal (IOS) changes during rSD waves.

More Related Videos

Live Imaging of Nicotine Induced Calcium Signaling and Neurotransmitter Release Along Ventral Hippocampal Axons

Live Imaging of Nicotine Induced Calcium Signaling and Neurotransmitter Release Along Ventral Hippocampal Axons

Published on: June 24, 2015

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration

Published on: February 10, 2012

Related Experiment Videos

Last Updated: May 25, 2026

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices

Published on: October 29, 2012

Live Imaging of Nicotine Induced Calcium Signaling and Neurotransmitter Release Along Ventral Hippocampal Axons

Live Imaging of Nicotine Induced Calcium Signaling and Neurotransmitter Release Along Ventral Hippocampal Axons

Published on: June 24, 2015

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration

Published on: February 10, 2012

Induced excitotoxicity using NMDA (N-methyl-D-aspartate) and assessed protective effects of nicotine and epibatidine.

Main Results:

Nicotine demonstrated significant neuroprotective effects against NMDA-induced excitotoxicity.
Nicotine application decreased the propagation velocity of rSD waves.
Epibatidine, a specific nAChR agonist, mimicked nicotine's protective effects.

Conclusions:

Nicotine exerts neuroprotective effects in the retina against excitotoxic insults, mediated by glutamate receptor activation.
Nicotine's modulation of rSD wave velocity suggests a role in regulating neuronal excitability.
These findings highlight the potential of nAChR agonists as therapeutic agents for retinal neuroprotection.